Yuanhe Capital logo

Yuanhe Capital

Asia, Liaoning, China, Yantai

Description

Yuanhe Capital invests in semiconductors, new energy, new materials, biomedicine, advanced manufacturing and other fields.

Investor Profile

Yuanhe Capital has made 3 investments, with 2 in the past 12 months and 33% as lead.

Stage Focus

  • Series B (33%)
  • Seed (33%)
  • Series A (33%)

Country Focus

  • China (67%)
  • United States (33%)

Industry Focus

  • Manufacturing
  • Association
  • Biotechnology
  • Non Profit
  • Artificial Intelligence (Ai)
  • Education
  • Software
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yuanhe Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Qiandao Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
Ligong investment
Asia, Shanghai, China, Putuo
Co-Investments: 1
GF Venture Capital
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
DT Capital Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Finnova Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
China Merchants Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Huajin Capital
Asia, Guangdong, China, Zhuhai
Co-Investments: 1
Horus Capital
Asia, Shandong, China, Qingdao Shi
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by Yuanhe Capital?

Luology

Weifang, Shandong, China

Luology is a pioneering domestic semiconductor transient heat testing equipment R&D company.

ManufacturingSemiconductor
Series AFeb 12, 2025
Amount Raised: $1,368,270
Keli Spoken Language

Beijing, Beijing, China

Keli Spoken Language is an AI oral learning software provider to giving customers with an effective English speaking improvement experience.

Artificial Intelligence (AI)EducationSoftware
SeedNov 11, 2024
MabPlex International

Fremont, California, United States

MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals.

AssociationBiotechnologyManufacturingNon Profit
Series BJun 8, 2020
Amount Raised: $70,708,356